Investments in Other Entities (Tables)

3 Months Ended

Mar. 31, 2023

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Equity Method Investments

Investments in other entities – equity method consisted of the following (in thousands):

	December 31, 2022		Initial Investment		Allocation of Income (Loss)		Funding		Distribution		March 31, 2023
LaSalle Medical Associates – IPA Line of Business	$	5,684	$	—	$	2,165	$	—	$	—	$	7,849
Pacific Medical Imaging & Oncology Center, Inc.	1,878		—		8		—		—		1,886
531 W. College, LLC	17,281		—		(90)		—		—		17,191
One MSO, LLC	2,718		—		115		—		—		2,833
CAIPA MSO, LLC	12,738		—		249		—		—		12,987
James Song, M.D., A Professional Corporation	—		325		37		—		—		362
	$	40,299	$	325	$	2,484	$	—	$	—	$	43,108

LMA’s summarized balance sheets at March 31, 2023 and December 31, 2022, and summarized statements of income for the three months ended March 31, 2023 and 2022, with respect to its IPA line of business are as follows (in thousands):

Balance Sheets

	March 31, 2023		December 31, 2022
	(unaudited)		(unaudited)
Assets
Cash and cash equivalents	$	14,873	$	15,671
Receivables, net	12,526		5,064
Prepaid assets	6,952		5,032
Loan receivable	2,250		2,250
Restricted cash	703		700
Total assets	$	37,304	$	28,717
Liabilities and stockholders' equity
Current liabilities	$	30,260	$	30,331
Stockholders’ equity (deficit)	7,044		(1,614)
Total liabilities and stockholders’ equity	$	37,304	$	28,717

Statements of Income

	Three months ended March 31,
	2023		2022
	(unaudited)		(unaudited)
Revenues	$	67,619	$	67,566
Expenses	58,964		61,786
Income from operations	8,655		5,780
Other Income	3		—
Net income	$	8,658	$	5,780